arrow
F

Frank Berthold

University of Cologne
H指数:76
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

International neuroblastoma risk group consortium: a model of networking for rare cancers
2025-08-250
OAAI
Sensitive liquid biopsy monitoring correlates with outcome in the prospective international GPOH-DCOG high-risk neuroblastoma RT-qPCR validation study
2024-12-260
OAAI
Asymmetric Adrenals: Sexual Dimorphism of Adrenal Tumors

不对称肾上腺: 肾上腺肿瘤的性二态性

2023-08-308
OA
Genomic ALK alterations in primary and relapsed neuroblastoma
2023-02-1726
OAAI
Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR

延长诱导化疗不能改善高危神经母细胞瘤患者的预后: 随机开放标签GPOH试验NB2004-HR的结果

2020-03-0135
OAAI
Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation (vol 119, pg 282, 2018)

GPOH NB97试验对高危神经母细胞瘤儿童的长期结果,比较大剂量化疗与自体干细胞移植和口服化疗作为巩固 (119卷,282页,2018页)

2019-09-242
OAAI
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients

神经母细胞瘤患者转移性疾病的循环microRNA生物标志物

2018-12-0627
OA
THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents

THROMBOTECT-一项比较低分子量肝素,抗凝血酶和普通肝素在儿童和青少年急性淋巴细胞白血病诱导治疗期间预防血栓的随机研究

2018-09-2789
OAAI
Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation

GPOH NB97试验对高危神经母细胞瘤儿童的长期结果,比较大剂量化疗与自体干细胞移植和口服化疗作为巩固

2018-07-1128
OAAI
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial

伊马替尼一线治疗儿童和青少年慢性粒细胞白血病: 一项III期临床试验的结果

LEUKEMIA
IF13.4
2018-06-2082
PREAI
Molecular Classification Substitutes for the Prognostic Variables Stage, Age, and MYCN Status in Neuroblastoma Risk Assessment

神经母细胞瘤风险评估中预后变量阶段,年龄和MYCN状态的分子分类替代

2017-12-0121
OAAI
Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project

加速神经母细胞瘤的药物开发-新药开发战略: 儿童癌症的创新疗法,欧洲儿童和青少年癌症研究网络和国际儿科肿瘤学会欧洲神经母细胞瘤项目

2017-06-2640
OAAI
Recommendations for the Standardization of Bone Marrow Disease Assessment and Reporting in Children With Neuroblastoma on Behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group

代表国际神经母细胞瘤反应标准骨髓工作组对神经母细胞瘤患儿骨髓疾病评估和报告标准化的建议

CANCER
IF5.1
2016-12-1679
OAAI
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma

多种机制干扰let-7 miRNA在神经母细胞瘤中的生物发生和功能

2016-07-150
PRE